# Tildrakizumab (Genetical Recombination) S.C. Injection 100mg Syringe (イルミア皮下注１００ｍｇシリンジ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3999456G1025). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3999456G1025
- **Product name (Japanese):** イルミア皮下注１００ｍｇシリンジ
- **English title:** Tildrakizumab (Genetical Recombination) S.C. Injection 100mg Syringe
- **Active ingredient:** チルドラキズマブ（遺伝子組換え）
- **Active ingredient (INN):** Tildrakizumab (Genetical Recombination)
- **Strength / unit:** １００ｍｇ１ｍＬ１筒
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 399 Other metabolic agents (n.e.c.) (他に分類されない代謝性医薬品)
- **Manufacturer:** Sun Pharma Japan (サンファーマ)
- **NHI price (reference only):** JPY 486197 per １００ｍｇ１ｍＬ１筒
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3999456G1025
- **JSON:** https://www.nifujipharma.com/api/drugs/3999456G1025

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Tildrakizumab%20(Genetical%20Recombination)%20S.C.%20Injection%20100mg%20Syringe%20(%E3%82%A4%E3%83%AB%E3%83%9F%E3%82%A2%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%91%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87%E3%82%B7%E3%83%AA%E3%83%B3%E3%82%B8)%20%2F%20YJ%203999456G1025#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.